A detailed history of Xponance, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Xponance, Inc. holds 3,889 shares of VCEL stock, worth $176,521. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,889
Holding current value
$176,521
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$40.05 - $59.11 $155,754 - $229,878
3,889 New
3,889 $213,000
Q1 2024

May 13, 2024

BUY
$32.52 - $52.33 $157,656 - $253,695
4,848 New
4,848 $252,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.14B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.